ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Multivitamin Use Doesn’t Impact Outcomes, Study Finds

September 24, 2010

Advocacy: Friends To Continue Another Year

June 13, 1997

Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say

May 14, 2010

CCRU, CCSP Projects Described; Plans Listed for DRCCA Applications Branch

November 11, 1983

Funding Opportunities

March 7, 2003

Opposition To Lederberg May Have Caused Delay In Panel Appointments; FY 19809 Funds Held Up

October 5, 1979